
Krishna Pharmachem Industries Private Limited
About Krishna Pharmachem Industries Private Limited
Data last updated:
Krishna Pharmachem Industries Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 17 November 1995.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC073941.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.68 Lakh. It was led by directors Mohan Lal and Deepak Arora.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at 1009/7 Mehrauli, New Delhi, Delhi, India – 110030.
Company details
Contact details
Krishna Pharmachem Industries Private Limited's registered office is in New Delhi, Delhi.
- Registered Address1009/7 Mehrauli, New Delhi, Delhi, India – 110030
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Krishna Pharmachem Industries Private Limited
FY 2016 filings availableFinancial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Krishna Pharmachem Industries Private Limited, buy the company report.
Board of directors of Krishna Pharmachem Industries Private Limited
Krishna Pharmachem Industries has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohan Lal | Director | 04 Jul 2005 | 21 Years 4 Months | As last reported |
| Deepak Arora | Director | 04 Jul 2005 | 21 Years 4 Months | As last reported |
Legal cases
No court or tribunal cases involving Krishna Pharmachem Industries Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Krishna Pharmachem Industries Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Krishna Pharmachem Industries Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Krishna Pharmachem Industries Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Deepak Arora was appointed as Director on 04 Jul 2005.
Frequently asked questions
Krishna Pharmachem Industries has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Krishna Pharmachem Industries was a private limited company based in New Delhi, Delhi, India. The company worked in other wholesale, within the trading industry. It was incorporated on 17 November 1995 and is registered under CIN U74899DL1995PTC073941. The company has been struck off by the Registrar of Companies and is no longer operational.
Krishna Pharmachem Industries had 2 directors:
- Mohan Lal - Director
- Deepak Arora - Director
The CIN (Corporate Identification Number) of Krishna Pharmachem Industries is U74899DL1995PTC073941. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Krishna Pharmachem Industries is at 10097 Mehrauli, New Delhi, Delhi, India – 110030.
Krishna Pharmachem Industries was incorporated on 17 November 1995. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Krishna Pharmachem Industries on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
Krishna Pharmachem Industries operated in the trading industry, in the other wholesale segment. It worked in this industry before it was struck off.
Deepak Arora was appointed as Director on 04 Jul 2005. Mohan Lal was appointed as Director on 04 Jul 2005.
The compliance status of Krishna Pharmachem Industries is active non-compliant as of 28 August 2026.

